Atıf Formatları
Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Ozkan Et Al. , "Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells," CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5, pp.261-271, 2004

Ozkan, A. Et Al. 2004. Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells. CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5 , 261-271.

Ozkan, A., Ayhan, A. G., & Fiskin, K., (2004). Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells. CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5, 261-271.

Ozkan, AYSUN, Ayşe Gül Ayhan, And KAYAHAN FIŞKIN. "Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells," CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5, 261-271, 2004

Ozkan, AYSUN Et Al. "Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells." CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5, pp.261-271, 2004

Ozkan, A. Ayhan, A. G. And Fiskin, K. (2004) . "Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells." CELL BIOLOGY AND TOXICOLOGY , vol.20, no.5, pp.261-271.

@article{article, author={AYSUN ÖZKAN Et Al. }, title={Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells}, journal={CELL BIOLOGY AND TOXICOLOGY}, year=2004, pages={261-271} }